Drug Topics
NOVEMBER 23, 2022
In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.
Pharmacy Times
NOVEMBER 23, 2022
Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 23, 2022
Take a look back at our most popular diabetes coverage for 2022.
Pharmacy Times
NOVEMBER 23, 2022
As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
NOVEMBER 23, 2022
The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes. Standard treatment for the condition involves replacing the missing or deficient clotting factor to improve the body’s ability to stop bleeding and promot
pharmaphorum
NOVEMBER 23, 2022
The US regulator has started a priority, six-month review of Takeda’s dengue fever vaccine TAK-003 – tipped as a potential blockbuster product – making a decision likely in the first half of 2023. The Japanese pharma said it has filed for approval of TAK-003 with the FDA for the prevention of dengue disease caused by any dengue virus serotype in individuals aged four through 60.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 23, 2022
Patients with cystic fibrosis may benefit from a 1000 mg vitamin C supplement, which can increase the bioavailability of other antioxidants.
pharmaphorum
NOVEMBER 23, 2022
Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges. They have suffered from an overwhelming diagnosis experience that has left them feeling misunderstood, isolated, and desperate for someone to help them connect symptoms and make sense of the sheer volume of information. Many will also face barriers to care, where access to specialists is limited and often geographically out of reach.
Pharmacy Times
NOVEMBER 23, 2022
For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.
Fierce Healthcare
NOVEMBER 23, 2022
Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare. pminemyer. Wed, 11/23/2022 - 11:12.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
NOVEMBER 23, 2022
The adeno-associated virus vector-based gene therapy is the first gene therapy to be approved by the FDA for hemophilia B.
Fierce Pharma
NOVEMBER 23, 2022
Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. zbecker. Wed, 11/23/2022 - 10:10.
Pharma Tutor
NOVEMBER 23, 2022
Klotho : A hope for the acute kidney injury-diabetes comorbidity. admin. Thu, 11/24/2022 - 10:12. About Authors. Ajinath Kale, Anil Bhanudas Gaikwad*. Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, India. *anil.gaikwad@pilani.bits-pilani.ac.in.
STAT
NOVEMBER 23, 2022
Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information through a tracking tool on their websites, prominent systems like UPMC, Advocate Aurora, and Duke Health are still contending with the resulting legal action. The Markup and STAT News co-published an investigation in June that found one-third of Newsweek’s top 100 U.S. hospitals were using a tracker called Meta Pixel that sends Meta, formerly known as Facebook, data whenever pat
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
NOVEMBER 23, 2022
CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.
European Pharmaceutical Review
NOVEMBER 23, 2022
The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU). The QIG, set up in September 2022, is composed of eight members with backgrounds in chemical, biological quality assessment and Good Manufacturing Practice (GMP) inspections, who report
The Checkup by Singlecare
NOVEMBER 23, 2022
Cinnamon benefits | Types of cinnamon | Dosage and side effects | Warnings. Cinnamon is synonymous with fall and winter. It is a popular spice, often used in recipes like pies, mulled cider, and cookies. On top of that, it’s one of the most recognized scents of the season. However, the spice is beneficial beyond the happy, homey feeling it gives you when you catch a whiff.
ISPE
NOVEMBER 23, 2022
ISPE Represented at PIC/S 50th Anniversary Event. Trudy Patterson. Wed, 11/23/2022 - 06:50. iSpeak Blog. iSpeak. ISPE Represented at PIC/S 50th Anniversary Event. Robert W. Tribe. 23 November 2022. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) celebrated its 50th anniversary at a special symposium in Dublin, Ireland on 4 October 2022. Since the first meeting of the PIC Committee in 1972, PIC/S has come a long way!
STAT
NOVEMBER 23, 2022
When Ken Duckworth was a child, his family didn’t talk about mental health, especially not his father’s bipolar disorder. It was an untouchable topic, but Duckworth knew his father shouldn’t be seen as a lost cause. Instead, his father and others like him might actually have critical expertise on how to navigate the world with mental illness — expertise they gained not through books and studying but through lived experience.
DiversifyRx
NOVEMBER 23, 2022
ACOs are one of the many organizations that pharmacy owners can partner with to bring better patient care and increase revenues. In this blog, our good friend Kris Rhea from Biolyte will help us dive into ACOs and their impact on the independent pharmacy owner. About Kris. Kris has been working in the independent pharmacy business for about a decade now and is passionate about the community service model that independent pharmacy is all about.
STAT
NOVEMBER 23, 2022
The U.S. has two separate health care systems: one for people who aren’t incarcerated, and one for people behind bars. Since 2006, physician and researcher Emily Wang has been working to integrate the two. “There’s really no glue, no connection between these health care systems,” Wang said. “When you have two million individuals cycling in and out of two disparate health care systems, your first thought — and I was a young physician at the time —
The Checkup by Singlecare
NOVEMBER 23, 2022
On Nov. 17, the U.S. Food and Drug Administration (FDA) approved the first drug to delay the onset of Type 1 diabetes. Tzield ( teplizumab-mzwv ) , manufactured by Provention Bio, “adds an important new treatment option for certain at-risk patients,” John Sharretts, MD, director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research, said in a statement.
STAT
NOVEMBER 23, 2022
Yale and Harvard Law Schools recently announced they would no longer participate in U.S. News & World Report’s (USNWR) flawed ranking system, followed closely by additional schools. The nation’s medical schools need to follow their lead. Why? The USNWR ranking system is in direct opposition to medical schools’ goal of educating a well-trained, diverse, and culturally competent medical workforce.
pharmaphorum
NOVEMBER 23, 2022
Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and discuss not only its consulting operations, but the company’s Smart Reviewer, and their own assessment of the industry event itself. Speaking with Kornelia Lencz, senior manager at EY Consulting and a business solutions lead for the EY Smart Reviewer Platform – after a spur-of-the-moment, yet highly interesti
STAT
NOVEMBER 23, 2022
LOS ANGELES — In a verdict that could affect countless claims by athletes who sue sports organizations for head injuries, a Los Angeles jury on Tuesday rejected a lawsuit seeking $55 million by the widow of a former USC football player who said the NCAA failed to protect him from repeated head trauma that led to his death. Matthew Gee, a linebacker on the 1990 Rose Bowl-winning squad, endured an estimated 6,000 hits as a college athlete, lawyers for his widow said.
Fierce Pharma
NOVEMBER 23, 2022
Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status. kdunleavy. Wed, 11/23/2022 - 07:18.
STAT
NOVEMBER 23, 2022
LAS VEGAS — Google has honed its message for hospital systems wary of moving their data to its cloud services: We are going to make this very easy for you. At the HLTH conference in Las Vegas this month, the company emphasized products and services that reduce the technical challenges health systems face as they look to modernize their technology infrastructure.
Fierce Healthcare
NOVEMBER 23, 2022
ACA signups top 3M since start of open enrollment, a 17% bump compared to last year. rking. Wed, 11/23/2022 - 11:58.
STAT
NOVEMBER 23, 2022
Happy Thanksgiving Eve from STAT reporter Andrew Joseph, filling in for the day. A note that this newsletter is taking a break Thursday and Friday, something to be thankful for indeed. Now, how to leave you before the big day? Sir Pharmalot himself suggested we make a mention of where turkey futures stand this morning, in case anyone is trying to score a last-minute turkey at bargain prices.
Fierce Healthcare
NOVEMBER 23, 2022
How a new fertility business hopes to disrupt the traditional investor approach and preserve clinician decision-making. agliadkovskaya. Wed, 11/23/2022 - 13:34.
Fierce Pharma
NOVEMBER 23, 2022
On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. kdunleavy. Wed, 11/23/2022 - 09:35.
Pharmacy Times
NOVEMBER 23, 2022
IPX203 is a novel, oral formulation of carbidopa/levodopa extended-release capsules.
OctariusRx
NOVEMBER 23, 2022
Happy Thanksgiving to all our team members, clients, vendors, and their families. Thanksgiving is about friends, family and giving thanks. From our OctariusRx family to yours, thank you! We are grateful for your support throughout the year. We hope everyone can enjoy some downtime with their loved ones during this Thanksgiving. The Consultant Pharmacists at OctariusRx provide guidance on safe medication management, survey readiness and cost savings to ambulatory healthcare facilities/surgery ce
Fierce Pharma
NOVEMBER 23, 2022
J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial. fkansteiner. Wed, 11/23/2022 - 09:26.
Expert insights. Personalized for you.
196 
Let's personalize your content